Meanwhile, enzyme-linked immunosorbent assay (ELISA) revealed that serum SP levels were up-regulated in patients with CKD (Figure 1E) and were correlated to clinical features (Supplementary Table S5). The gene discussed is TFF2; the disease is chronic kidney disease.